Topamax Side Effects

If side effects do bother people, most commonly, Topamax will slow you down, or make you feel like you’re in a fog. This includes slower reflexes, trouble thinking or concentrating, trouble thinking of the right word (and other speech problems), tiredness, poor coordination, and dizziness.

Topiramate may also cause tingling in your hands or feet, shakiness, depression, nausea, memory problems, and visual problems (such as double vision). It has also been known to bring on respiratory infections.

(Note: early in 2008, the FDA in the USA released a report that topiramate and other antiseizure medication significantly increased the risk of suicidal thoughts or behaviour. Special caution should be taken with those who are at risk or have a history of depression.)

Remember, it’s not as if you’re going to suffer from all these problems – they are simply the Topamax most common side effects, and you may not have much trouble, or may experience one or some of the above.

Topiramate may also cause birth defects if taken while pregnant. It also passes into the breast milk. Unless crucial, Topamax is not taken during pregnancy or breastfeeding.
Less common side effects
As with any drug, there is a large list of possible side effects. But most things on the list are very rare. If you do experience problems, it’s nice to have the list so that you know what may be the cause. But generally, these are not a reason to worry.

Some of the less common Topamax side effects include: pain (ie chest, leg), mood changes (ie aggression, restlessness), rash, body odour, appetite loss and weight loss, constipation, hearing loss, and menstrual disorders. Check here for a more complete explanation of Topamax side effects.

Topamax (topiramate) has been allied with the development of oral clefts – cleft lip and/or cleft palate – in children born to women who took the remedy during early pregnancy. Today, the U.S. Food & Drug Administration (FDA) said that Topamax, until that time classified as a Pregnancy Category C drug, will not be set in Pregnancy Category D.

According to the FDA, the Pregnancy class D designation means that there is affirmative evidence of human fetal risk based on human data, but the probable benefits of Topamax in pregnant women may compensate the risks in definite situations. The new arrangement also applies to standard forms of Topamax.

Topamax is an anticonvulsant prescription approved for use alone or with other drugs to care for other patients with epilepsy who have certain types of seizures. Topamax is also accepted for use to prevent migraine headaches.

The FDA was certain to move Topamax to Pregnancy Category D after Data from the North American Antiepileptic Drug (AED) Pregnancy Registry indicated with the intention of infants exposed to Topamax as a single therapy throughout the first trimester of pregnancy experienced a 1.4 percent frequency of oral clefts, compared with a prevalence of 0.38 percent – 0.55 percent in infants uncovered to other antiepileptic drugs. Infants of mothers who did not have epilepsy and were not being cared for with other antiepileptic medications had a prevalence of 0.07 percent.

According to the FDA, data from the United Kingdom Epilepsy and Pregnancy inventory helped the North American AED Pregnancy Registry data.

Oral clefts are birth defects that take place when pieces of the lip or palate do not completely combine together early in the first trimester of pregnancy, a time when many women do not know they are pregnant. The defects sort from a small notch in the lip to a rut that runs into the roof of the mouth and nose, possibly leading to tribulations with eating, talking, and to ear infections. Surgery often is performed to close the lip and palate and most kids do well after treatment.

Healthcare providers have been told by the FDA to inform women of childbearing age of the greater than before risk for oral clefts when Topamax is used in the first trimester of pregnancy, and to weigh the reimbursement and risks of Topamax when giving this drug to women of childbearing age, particularly when treating a situation not regularly connected with undying injury or death. If they come to a decision to prescribe Topamax to women of childbearing age, doctors should propose use of useful contraception.